Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 17;7(5Part B):672-674.
doi: 10.1016/j.ijwd.2021.07.003. eCollection 2021 Dec.

Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis

Terri Shih  1 , Justine R Seivright  1 , Shanice A McKenzie  2 , Christina L Harview  3 , Allison K Truong  4 , Vivian Y Shi  5 , Richard G Bennett  1   6 , Jennifer L Hsiao  1
Affiliations

Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis

Terri Shih et al. Int J Womens Dermatol. .
No abstract available

Keywords: Hidradenitis suppurativa; gender.

PubMed Disclaimer

Conflict of interest statement

Dr Jennifer L. Hsiao is on the board of directors for the Hidradenitis Suppurativa Foundation and has served as an advisor for Novartis and a speaker for AbbVie. Dr Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation and has served as an advisor, investigator, and/or speaker for Sanofi Genzyme, Regeneron, AbbVie, Burt's Bees, Dermira, Eli Lilly, Novartis, Pfizer, Galderma, Leo Pharma, SUN Pharma, Menlo Therapeutics, GpSkin, and Skin Actives Scientific. There was no financial transaction for the preparation of this manuscript. The other authors have no relevant disclosures.

Figures

Fig 1
Fig. 1
Patient comorbidities. HS, hidradenitis suppurativa; SAPHO, synovitis, acne, pustulosis, hyperostosis, osteitis. *p < .05 indicates statistically significant difference between genders. ^Excluding skin cancers
See this image and copyright information in PMC

References

    1. Gasparic J, Theut Riis P, Jemec GB. Recognizing syndromic hidradenitis suppurativa: A review of the literature. J Eur Acad Dermatology Venereol. 2017;31:1809–1816. - PubMed
    1. Patel N, McKenzie SA, Harview CL, Truong AK, Shi VY, Chen L, et al. Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study. J Dermatolog Treat. 2021;32(4):473. - PubMed
    1. Sartorius K, Emtestam L, Jemec GBE, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831–839. - PubMed
    1. Schrader AMR, Deckers IE, Der Zee HH Van, Boer J, Prens EP. Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol. 2014;71(3):460–467. - PubMed
    1. Zimman S, Comparatore MV, Vulcano AF, Absi ML, Mazzuoccolo LD. Hidradenitis supurativa: Una aproximación a su prevalencia, características clínicas, comorbilidades y tiempo al diagnóstico, en un hospital universitario de Buenos Aires, Argentina. Actas Dermosifiliogr. 2019;110:297–302. - PubMed